185 related articles for article (PubMed ID: 2940136)
21. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
Hechtman P; Boulay B; Bayleran J; Andermann E
Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
[TBL] [Abstract][Full Text] [Related]
22. The beta-hexosaminidase deficiency disorders: development of a clinical paradigm in the mouse.
Tifft CJ; Proia RL
Ann Med; 1997 Dec; 29(6):557-61. PubMed ID: 9562524
[TBL] [Abstract][Full Text] [Related]
23. Frequency of hexosaminidase A variant alleles among Ashkenazi Jews and prenatal diagnosis of GM2 gangliosidosis.
Navon R; Adam A
Am J Hum Genet; 1985 Sep; 37(5):1031-3. PubMed ID: 2931975
[No Abstract] [Full Text] [Related]
24. [Genetic deficiencies of beta-N-acetylhexosaminidase A and B: Tay-Sachs and Sandhoff diseases (GM2-gangliosidosis)].
Suzuki K
Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):721-7. PubMed ID: 2978703
[No Abstract] [Full Text] [Related]
25. Promoters for the human beta-hexosaminidase genes, HEXA and HEXB.
Norflus F; Yamanaka S; Proia RL
DNA Cell Biol; 1996 Feb; 15(2):89-97. PubMed ID: 8634145
[TBL] [Abstract][Full Text] [Related]
26. [Activity and appearance of isoenzyme spectrums of some lysosomal hydrolases in biopsy material of human chorion].
Beĭer EM; Vidershaĭn GIa; Bakharev VA; Rozovskiĭ IS
Vopr Med Khim; 1983; 29(2):130-3. PubMed ID: 6222539
[TBL] [Abstract][Full Text] [Related]
27. The X-ray crystal structure of human beta-hexosaminidase B provides new insights into Sandhoff disease.
Maier T; Strater N; Schuette CG; Klingenstein R; Sandhoff K; Saenger W
J Mol Biol; 2003 May; 328(3):669-81. PubMed ID: 12706724
[TBL] [Abstract][Full Text] [Related]
28. The biochemical basis of gangliosidoses.
Sandhoff K; Conzelmann E
Neuropediatrics; 1984 Sep; 15 Suppl():85-92. PubMed ID: 6242704
[No Abstract] [Full Text] [Related]
29. Two small deletion mutations of the HEXB gene are present in DNA from a patient with infantile Sandhoff disease.
McInnes B; Brown CA; Mahuran DJ
Biochim Biophys Acta; 1992 Apr; 1138(4):315-7. PubMed ID: 1532910
[TBL] [Abstract][Full Text] [Related]
30. Degradation of keratan sulfate by beta-N-acetylhexosaminidases in GM2-gangliosidosis.
Yutaka T; Okada S; Kato T; Yabuuhi H
Clin Genet; 1982 Mar; 21(3):196-202. PubMed ID: 6212169
[TBL] [Abstract][Full Text] [Related]
31. Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases.
Phaneuf D; Wakamatsu N; Huang JQ; Borowski A; Peterson AC; Fortunato SR; Ritter G; Igdoura SA; Morales CR; Benoit G; Akerman BR; Leclerc D; Hanai N; Marth JD; Trasler JM; Gravel RA
Hum Mol Genet; 1996 Jan; 5(1):1-14. PubMed ID: 8789434
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and molecular characterization of non-classic forms of Tay-Sachs disease in Brazil.
Rozenberg R; Kok F; Burin MG; Sá Miranda MC; Vasques C; Henriques-Souza AM; Giugliani R; Vainzof M; Pereira LV
J Child Neurol; 2006 Jun; 21(6):540-4. PubMed ID: 16948947
[TBL] [Abstract][Full Text] [Related]
33. Hexosaminidase A deficiency in adults.
Navon R; Argov Z; Frisch A
Am J Med Genet; 1986 May; 24(1):179-96. PubMed ID: 2939718
[TBL] [Abstract][Full Text] [Related]
34. Molecular heterogeneity in the infantile and juvenile forms of Sandhoff disease (O-variant GM2 gangliosidosis).
O'Dowd BF; Klavins MH; Willard HF; Gravel R; Lowden JA; Mahuran DJ
J Biol Chem; 1986 Sep; 261(27):12680-5. PubMed ID: 3017984
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.
Mark BL; Mahuran DJ; Cherney MM; Zhao D; Knapp S; James MN
J Mol Biol; 2003 Apr; 327(5):1093-109. PubMed ID: 12662933
[TBL] [Abstract][Full Text] [Related]
36. Lysosomal enzymes in ataxia: discovery of two new cases of late onset hexosaminidase A and B deficiency (adult Sandhoff disease) in French Canadians.
Barbeau A; Plasse L; Cloutier T; Paris S; Roy M
Can J Neurol Sci; 1984 Nov; 11(4 Suppl):601-6. PubMed ID: 6239679
[TBL] [Abstract][Full Text] [Related]
37. Natural history and inherited disorders of a lysosomal enzyme, beta-hexosaminidase.
Neufeld EF
J Biol Chem; 1989 Jul; 264(19):10927-30. PubMed ID: 2525553
[No Abstract] [Full Text] [Related]
38. Detection of Tay-Sachs disease carriers among individuals with thermolabile hexosaminidase B.
Peleg L; Goldman B
Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):65-9. PubMed ID: 8003579
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus transformed lymphoid cell lines as a new model system in culture for the study of GM2-gangliosidoses: Tay-Sachs and Sandhoff diseases.
Maret A; Salvayre R; Negre A; Bes JC; Douste-Blazy L
Biol Cell; 1985; 53(3):293-6. PubMed ID: 2990625
[TBL] [Abstract][Full Text] [Related]
40. The juvenile and chronic forms of GM2 gangliosidosis: clinical and enzymatic heterogeneity.
Specola N; Vanier MT; Goutières F; Mikol J; Aicardi J
Neurology; 1990 Jan; 40(1):145-50. PubMed ID: 2136940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
